View the DIFLUVID registration information details.
Back to drug list
ItemsDrug Registration information
ID303
No303
Brand NameDIFLUVID
IngredientsFLUCONAZOLE 150 MG
Dosage FormCAPSULE
Primary PackagingBLISTERPACK
Storage
Shelf Life3 YEARS
Pack Size4 CAPSULE/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
Indications- MUCOSAL CANDIDIASIS. THESE INCLUDE OROPHARYNGEAL, ESOPHAGEAL, NON INVASIVE BRONCHOPULMONARY INFECTIONS, CANDIDURIA, - GENITAL CANDIDIASIS : VAGINAL CANDIDIASIS, ACUTE OR RECURRENT AND PROPHYLAXIS TO REDUCE THE INCIDENCE OF RECURRENT VAGINAL CANDIDIASIS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionLIGHT TURQUOISE OPAQUE/LIGHT TURQUOISE OPAQUE CAPSULE WITH "HOVID" PRINTED ON ONE END AND "FL 150"PRINTED ON THE OTHER END OF THE CAPSULE. THE CAPSULE IS FILLED WITH WHITE TO OFF - WHITE POWDER.
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 I 4211/17
FDD Registration Date07/06/2023
Expiry Date06/06/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA